Kelley Drye’s Generic Pharmaceuticals Team Mentioned in An Article About Price-Fixing Lawsuits Against Generic Drugmakers

Kelley Drye Warren LLP was mentioned in a recent article highlighting their representation of Wockhardt USA, with partners Clifford Katz, Damon W. Suden, and Pro Bono Counsel Marisa Lorenzo leading the charge. The article discusses a coalition of state attorneys general pushing a Connecticut federal court to prioritize one of two related price-fixing lawsuits against generic drugmakers. The case involving Teva Pharmaceuticals, with its broader allegations, is seen as crucial for influencing settlement negotiations with other pharmaceutical companies. Both lawsuits accuse drugmakers of colluding to inflate prices on over 100 medications.

The article titled, States Want Teva Generic Price Fixing Case Tried 1st was published in Law360 on August 12, 2024.

A Law360 subscription may be required to read the article.

Kelley Drye’s Generic Pharmaceuticals Team has a deep understanding of the generic pharmaceutical industry, earned over a two-decade partnership working alongside generic companies.